Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Genetic Technologies

Our company is a leading-edge Australian life science company, specialising in genetics and genomics. We owe our success to being a global pioneer in recognising the importance of 'non-coding' DeoxyriboNucleic Acid (DNA). This research discovery enabled us to patent strategies by which non-coding variation in the DNA is utilised to analyse genetic material and also to map genes and traits of interest across all multi-cellular species. These patents form the basis of our substantial licensing activities. We also continue to develop a range of research projects to keep us at the forefront of the exciting new world of genetics. As well as our ongoing licensing and research activities, we have used our genetic expertise to develop a low cost, high throughput DNA testing laboratory. Genetic Technologies Limited is listed on the Australian Stock Exchange (ASX: GTG). Our shares are also listed on the NASDAQ Global Market via our Level II American Depositary Receipts (ADRs). These ADRs, each of which comprise 30 ordinary shares are listed under the ticker GENE.


Contact Details:
60-66 Hanover Street
Fitzroy Vic
3065
Australia
Tel:+61 3 9415 1135
Fax:+61 3 9417 2987
Email:
WWW:

www.gtg.com.au/




Recent Publications by Genetic Technologies:

EuPathDB: a portal to eukaryotic pathogen databases.
EuPathDB (http://EuPathDB.org; formerly ApiDB) is an integrated database...
17th November, 2009
Center for Tropical & Emerging Global Diseases, University of Georgia, Nucleic Acids Res. 2009 Nov 13.
DOI Direct Link
Dog attack: the application of canine DNA profiling in forensic casework.
More than 100,000 dog attacks occur each year in Australia and many go...
31st October, 2009
Genetic Technologies Limited, 60-66 Hanover Street, Fitzroy, VIC, 3065, Forensic Sci Med Pathol. 2009 Oct 30.
DOI Direct Link
Tick-susceptible Bos taurus cattle display an increased cellular response at the site of larval Rhipicephalus (Boophilus) microplus attachment, compared with tick-resistant Bos indicus cattle.
Cattle demonstrate divergent and heritable phenotypes of resistance and...
27th October, 2009
Cooperative Research Centre for Beef Genetic Technologies, Armidale 2351, Int J Parasitol. 2009 Oct 21.
DOI Direct Link
TriTrypDB: a functional genomic resource for the Trypanosomatidae.
TriTrypDB (http://tritrypdb.org) is an integrated database providing...
22nd October, 2009
Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Nucleic Acids Res. 2009 Oct 20.
DOI Direct Link
Suppressive subtractive hybridization analysis of Rhipicephalus (Boophilus) microplus larval and adult transcript expression during attachment and feeding.
Ticks, as blood-feeding ectoparasites, affect their hosts both directly...
20th October, 2009
Cooperative Research Centre for Beef Genetic Technologies, Australia; Vet Parasitol. 2009 Sep 20.
DOI Direct Link

View more Genetic Technologies research publications.

BioNews Results for Genetic Technologies:

NanoString Forges Closer Ties With Broad Institute to See What Genetic Tool Can Really Do
Xconomy:  Nov 18 2009 1:32PM Matching: genetic technologies
And the Price Goes Up
GenomeWeb:  Nov 16 2009 6:11PM Matching: genetic technologies
OTCBB-WNDM Announces Activation of BioPharma Division to Solicit Technology and Development Partners
KOTA Territory News:  Nov 12 2009 11:33AM Matching: genetic technologies
OTCBB-WNDM Announces Activation of BioPharma Division to Solicit Technology and Development Partners
KSLA:  Nov 12 2009 6:03AM Matching: genetic technologies
OTCBB-WNDM Announces Activation of BioPharma Division to Solicit Technology and Development Partners
Pharma Live:  Nov 11 2009 8:06PM Matching: genetic technologies
Promote your company here: BioNewsCast - Press Release Distribution

View more Genetic Technologies news.

Genetic Technologies Clinical Trials:

Phase 1/2 Safety and Efficacy Study of AAV-RPE65 Vector to Treat Leber Congenital Amaurosis

Genetic Technologies Patents:

US Patent No.Title
7037723 Recombinant herpes viruses for preparing recombinant adeno-associated viruses
6967018 Adiponectin gene therapy
5547660 Nail lacquer composition containing poly-hydroxystyrene

Genetic Technologies (GENE) Financial information Links from Barchart

GENE Quote from from Barchart.com
GENE Chart from from Barchart.com
GENE Profile from from Barchart.com
GENE Opinion from from Barchart.com

View more Genetic Technologies finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 365 times since April 2007, the link to the organisation's website has been followed 53 times

Recent Search Terms used to find this page: Applied Genetic Technologies stock | emerging and recombinant genetic technologies | .

Search for more companies in Fitzroy Vic

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Genetic Technologies

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.